Radioreceptor assay for insulin formulations

Area of Science:

• Biochemistry
• Pharmacology
• Analytical Chemistry

Background:

• Accurate quantification of pharmaceutical insulin formulations is crucial for therapeutic efficacy.
• Existing in vivo assays for insulin potency can be less precise and more complex.
• Development of sensitive and reliable in vitro assays is needed for quality control.

Purpose of the Study:

• To develop and validate a sensitive radioreceptor assay for pharmaceutical insulin formulations.
• To compare the precision and accuracy of the radioreceptor assay with in vivo methods.
• To assess the assay's performance with insulin preparations degraded during storage.

Main Methods:

• Utilized rat liver membranes and 125I-insulin for a radioreceptor assay.
• Employed unlabeled insulin and analogues to inhibit 125I-insulin binding in a concentration-dependent manner.
• Performed a three-point assay using insulin concentrations between 3 x 10(-9) and 3 x 10(-8) M.

Main Results:

• The radioreceptor assay demonstrated high sensitivity for pharmaceutical insulin formulations.
• Assay validity was confirmed by pharmacopoeial statistical requirements, with a coefficient of variation of 4%.
• Potency estimates from the radioreceptor assay correlated well with in vivo assay results, showing greater precision for degraded samples.

Conclusions:

• A sensitive and precise radioreceptor assay for pharmaceutical insulin formulations has been successfully developed.
• The assay meets pharmacopoeial standards and offers a reliable alternative to in vivo methods.
• This method provides accurate potency readings, particularly for stored or degraded insulin preparations.